LPCUF (Lee's Pharmaceutical Holdings) Other Long-Term Liabilities : $12.1 Mil (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings Other Long-Term Liabilities?

Lee's Pharmaceutical Holdings's other long-term liabilities for the quarter that ended in Jun. 2024 was $12.1 Mil.

Lee's Pharmaceutical Holdings's quarterly other long-term liabilities declined from Jun. 2023 ($14.5 Mil) to Dec. 2023 ($12.4 Mil) and declined from Dec. 2023 ($12.4 Mil) to Jun. 2024 ($12.1 Mil).

Lee's Pharmaceutical Holdings's annual other long-term liabilities declined from Dec. 2021 ($15.3 Mil) to Dec. 2022 ($14.5 Mil) and declined from Dec. 2022 ($14.5 Mil) to Dec. 2023 ($12.4 Mil).

Lee's Pharmaceutical Holdings Other Long-Term Liabilities Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Other Long-Term Liabilities Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Lee's Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Lee's Pharmaceutical Holdings Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Lee's Pharmaceutical Holdings Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

00950:Hong Kong L1PA:Germany

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines